nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—lung cancer	0.284	1	CbGaD
Neostigmine—ACHE—Irinotecan—lung cancer	0.121	0.227	CbGbCtD
Neostigmine—BCHE—Irinotecan—lung cancer	0.073	0.137	CbGbCtD
Neostigmine—BCHE—Cisplatin—lung cancer	0.0595	0.112	CbGbCtD
Neostigmine—ABCB1—Topotecan—lung cancer	0.038	0.0712	CbGbCtD
Neostigmine—ABCB1—Gefitinib—lung cancer	0.0347	0.0651	CbGbCtD
Neostigmine—ABCB1—Vinorelbine—lung cancer	0.0267	0.0502	CbGbCtD
Neostigmine—ABCB1—Crizotinib—lung cancer	0.0213	0.0399	CbGbCtD
Neostigmine—ABCB1—Gemcitabine—lung cancer	0.0208	0.039	CbGbCtD
Neostigmine—ABCB1—Erlotinib—lung cancer	0.0205	0.0385	CbGbCtD
Neostigmine—ABCB1—Paclitaxel—lung cancer	0.0188	0.0353	CbGbCtD
Neostigmine—ABCB1—Irinotecan—lung cancer	0.0185	0.0348	CbGbCtD
Neostigmine—ABCB1—Vinblastine—lung cancer	0.0165	0.0309	CbGbCtD
Neostigmine—ABCB1—Cisplatin—lung cancer	0.0151	0.0283	CbGbCtD
Neostigmine—ABCB1—Etoposide—lung cancer	0.0148	0.0279	CbGbCtD
Neostigmine—ABCB1—Docetaxel—lung cancer	0.0136	0.0255	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—lung cancer	0.0101	0.019	CbGbCtD
Neostigmine—ABCB1—Methotrexate—lung cancer	0.00981	0.0184	CbGbCtD
Neostigmine—BCHE—diaphragm—lung cancer	0.00535	0.542	CbGeAlD
Neostigmine—BCHE—respiratory system—lung cancer	0.00061	0.0619	CbGeAlD
Neostigmine—BCHE—bronchus—lung cancer	0.000502	0.0509	CbGeAlD
Neostigmine—BCHE—trachea—lung cancer	0.000451	0.0457	CbGeAlD
Neostigmine—ACHE—lymph node—lung cancer	0.000451	0.0457	CbGeAlD
Neostigmine—BCHE—cardiac atrium—lung cancer	0.000424	0.0429	CbGeAlD
Neostigmine—BCHE—bone marrow—lung cancer	0.000358	0.0363	CbGeAlD
Neostigmine—BCHE—lung—lung cancer	0.000324	0.0328	CbGeAlD
Neostigmine—ABCB1—respiratory system—lung cancer	0.000291	0.0295	CbGeAlD
Neostigmine—ABCB1—epithelium—lung cancer	0.000243	0.0246	CbGeAlD
Neostigmine—BCHE—lymph node—lung cancer	0.000222	0.0225	CbGeAlD
Neostigmine—ABCB1—trachea—lung cancer	0.000215	0.0218	CbGeAlD
Neostigmine—Convulsion—Cisplatin—lung cancer	0.000201	0.00152	CcSEcCtD
Neostigmine—Urticaria—Vinorelbine—lung cancer	0.000201	0.00151	CcSEcCtD
Neostigmine—Urinary tract disorder—Docetaxel—lung cancer	0.0002	0.00151	CcSEcCtD
Neostigmine—Muscle spasms—Paclitaxel—lung cancer	0.0002	0.00151	CcSEcCtD
Neostigmine—Diarrhoea—Erlotinib—lung cancer	0.0002	0.00151	CcSEcCtD
Neostigmine—Abdominal pain—Vinorelbine—lung cancer	0.0002	0.00151	CcSEcCtD
Neostigmine—Connective tissue disorder—Docetaxel—lung cancer	0.000199	0.0015	CcSEcCtD
Neostigmine—Nervous system disorder—Gemcitabine—lung cancer	0.000199	0.0015	CcSEcCtD
Neostigmine—Urethral disorder—Docetaxel—lung cancer	0.000199	0.0015	CcSEcCtD
Neostigmine—Skin disorder—Gemcitabine—lung cancer	0.000197	0.00149	CcSEcCtD
Neostigmine—Hyperhidrosis—Gemcitabine—lung cancer	0.000196	0.00148	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000196	0.00148	CcSEcCtD
Neostigmine—Dizziness—Topotecan—lung cancer	0.000195	0.00147	CcSEcCtD
Neostigmine—Hypotension—Irinotecan—lung cancer	0.000195	0.00147	CcSEcCtD
Neostigmine—Vomiting—Vinblastine—lung cancer	0.000193	0.00146	CcSEcCtD
Neostigmine—Dizziness—Erlotinib—lung cancer	0.000193	0.00146	CcSEcCtD
Neostigmine—Agitation—Paclitaxel—lung cancer	0.000191	0.00144	CcSEcCtD
Neostigmine—Headache—Vinblastine—lung cancer	0.00019	0.00144	CcSEcCtD
Neostigmine—Hypotension—Gemcitabine—lung cancer	0.00019	0.00143	CcSEcCtD
Neostigmine—Anaphylactic shock—Cisplatin—lung cancer	0.000189	0.00143	CcSEcCtD
Neostigmine—Insomnia—Irinotecan—lung cancer	0.000188	0.00142	CcSEcCtD
Neostigmine—Flushing—Docetaxel—lung cancer	0.000188	0.00142	CcSEcCtD
Neostigmine—Vomiting—Topotecan—lung cancer	0.000188	0.00142	CcSEcCtD
Neostigmine—Syncope—Paclitaxel—lung cancer	0.000187	0.00141	CcSEcCtD
Neostigmine—Loss of consciousness—Etoposide—lung cancer	0.000187	0.00141	CcSEcCtD
Neostigmine—Rash—Topotecan—lung cancer	0.000186	0.00141	CcSEcCtD
Neostigmine—Hypersensitivity—Vinorelbine—lung cancer	0.000186	0.0014	CcSEcCtD
Neostigmine—Dermatitis—Topotecan—lung cancer	0.000186	0.0014	CcSEcCtD
Neostigmine—Vomiting—Erlotinib—lung cancer	0.000186	0.0014	CcSEcCtD
Neostigmine—Dyspnoea—Irinotecan—lung cancer	0.000186	0.0014	CcSEcCtD
Neostigmine—Nervous system disorder—Cisplatin—lung cancer	0.000186	0.0014	CcSEcCtD
Neostigmine—Somnolence—Irinotecan—lung cancer	0.000185	0.0014	CcSEcCtD
Neostigmine—Headache—Topotecan—lung cancer	0.000185	0.0014	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000185	0.0014	CcSEcCtD
Neostigmine—Tachycardia—Cisplatin—lung cancer	0.000185	0.00139	CcSEcCtD
Neostigmine—Rash—Erlotinib—lung cancer	0.000184	0.00139	CcSEcCtD
Neostigmine—Dermatitis—Erlotinib—lung cancer	0.000184	0.00139	CcSEcCtD
Neostigmine—Convulsion—Etoposide—lung cancer	0.000184	0.00139	CcSEcCtD
Neostigmine—Skin disorder—Cisplatin—lung cancer	0.000184	0.00139	CcSEcCtD
Neostigmine—Insomnia—Gemcitabine—lung cancer	0.000184	0.00139	CcSEcCtD
Neostigmine—Headache—Erlotinib—lung cancer	0.000183	0.00138	CcSEcCtD
Neostigmine—Loss of consciousness—Paclitaxel—lung cancer	0.000183	0.00138	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—lung cancer	0.000183	0.00138	CcSEcCtD
Neostigmine—Hyperhidrosis—Cisplatin—lung cancer	0.000183	0.00138	CcSEcCtD
Neostigmine—Mediastinal disorder—Docetaxel—lung cancer	0.000183	0.00138	CcSEcCtD
Neostigmine—Asthenia—Vinorelbine—lung cancer	0.000181	0.00137	CcSEcCtD
Neostigmine—Arrhythmia—Docetaxel—lung cancer	0.000181	0.00137	CcSEcCtD
Neostigmine—Dyspnoea—Gemcitabine—lung cancer	0.000181	0.00137	CcSEcCtD
Neostigmine—Nausea—Vinblastine—lung cancer	0.000181	0.00136	CcSEcCtD
Neostigmine—Somnolence—Gemcitabine—lung cancer	0.00018	0.00136	CcSEcCtD
Neostigmine—Convulsion—Paclitaxel—lung cancer	0.00018	0.00136	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Irinotecan—lung cancer	0.00018	0.00136	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00018	0.00136	CcSEcCtD
Neostigmine—Pruritus—Vinorelbine—lung cancer	0.000179	0.00135	CcSEcCtD
Neostigmine—Mental disorder—Docetaxel—lung cancer	0.000178	0.00134	CcSEcCtD
Neostigmine—Arthralgia—Paclitaxel—lung cancer	0.000177	0.00134	CcSEcCtD
Neostigmine—Hypotension—Cisplatin—lung cancer	0.000177	0.00133	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000176	0.00133	CcSEcCtD
Neostigmine—Nausea—Topotecan—lung cancer	0.000175	0.00132	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000175	0.00132	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—lung cancer	0.000174	0.00131	CcSEcCtD
Neostigmine—Nausea—Erlotinib—lung cancer	0.000174	0.00131	CcSEcCtD
Neostigmine—Dry mouth—Paclitaxel—lung cancer	0.000173	0.00131	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—lung cancer	0.000173	0.00131	CcSEcCtD
Neostigmine—Diarrhoea—Vinorelbine—lung cancer	0.000173	0.0013	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000172	0.0013	CcSEcCtD
Neostigmine—ABCB1—bone marrow—lung cancer	0.00017	0.0173	CbGeAlD
Neostigmine—Gastrointestinal pain—Irinotecan—lung cancer	0.00017	0.00129	CcSEcCtD
Neostigmine—Anaphylactic shock—Paclitaxel—lung cancer	0.00017	0.00128	CcSEcCtD
Neostigmine—Muscle spasms—Docetaxel—lung cancer	0.00017	0.00128	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—lung cancer	0.000169	0.00128	CcSEcCtD
Neostigmine—Dyspnoea—Cisplatin—lung cancer	0.000169	0.00127	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—lung cancer	0.000168	0.00127	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—lung cancer	0.000168	0.00126	CcSEcCtD
Neostigmine—Shock—Paclitaxel—lung cancer	0.000167	0.00126	CcSEcCtD
Neostigmine—Dizziness—Vinorelbine—lung cancer	0.000167	0.00126	CcSEcCtD
Neostigmine—Nervous system disorder—Paclitaxel—lung cancer	0.000167	0.00126	CcSEcCtD
Neostigmine—Tachycardia—Paclitaxel—lung cancer	0.000166	0.00125	CcSEcCtD
Neostigmine—Skin disorder—Paclitaxel—lung cancer	0.000165	0.00125	CcSEcCtD
Neostigmine—Abdominal pain—Irinotecan—lung cancer	0.000165	0.00124	CcSEcCtD
Neostigmine—Hyperhidrosis—Paclitaxel—lung cancer	0.000164	0.00124	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000163	0.00123	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—lung cancer	0.000163	0.00123	CcSEcCtD
Neostigmine—Hypotension—Etoposide—lung cancer	0.000162	0.00122	CcSEcCtD
Neostigmine—Vomiting—Vinorelbine—lung cancer	0.000161	0.00121	CcSEcCtD
Neostigmine—Rash—Vinorelbine—lung cancer	0.000159	0.0012	CcSEcCtD
Neostigmine—Dermatitis—Vinorelbine—lung cancer	0.000159	0.0012	CcSEcCtD
Neostigmine—Hypotension—Paclitaxel—lung cancer	0.000159	0.0012	CcSEcCtD
Neostigmine—Headache—Vinorelbine—lung cancer	0.000158	0.00119	CcSEcCtD
Neostigmine—Syncope—Docetaxel—lung cancer	0.000158	0.00119	CcSEcCtD
Neostigmine—Loss of consciousness—Docetaxel—lung cancer	0.000155	0.00117	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000155	0.00117	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—lung cancer	0.000155	0.00117	CcSEcCtD
Neostigmine—ABCB1—lung—lung cancer	0.000154	0.0157	CbGeAlD
Neostigmine—Somnolence—Etoposide—lung cancer	0.000154	0.00116	CcSEcCtD
Neostigmine—Insomnia—Paclitaxel—lung cancer	0.000154	0.00116	CcSEcCtD
Neostigmine—Hypersensitivity—Irinotecan—lung cancer	0.000154	0.00116	CcSEcCtD
Neostigmine—Convulsion—Docetaxel—lung cancer	0.000153	0.00115	CcSEcCtD
Neostigmine—Dyspnoea—Paclitaxel—lung cancer	0.000151	0.00114	CcSEcCtD
Neostigmine—Somnolence—Paclitaxel—lung cancer	0.000151	0.00114	CcSEcCtD
Neostigmine—Arthralgia—Docetaxel—lung cancer	0.00015	0.00113	CcSEcCtD
Neostigmine—Nausea—Vinorelbine—lung cancer	0.00015	0.00113	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—lung cancer	0.00015	0.00113	CcSEcCtD
Neostigmine—Asthenia—Irinotecan—lung cancer	0.000149	0.00113	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000149	0.00113	CcSEcCtD
Neostigmine—Dry mouth—Docetaxel—lung cancer	0.000147	0.00111	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000147	0.00111	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—lung cancer	0.000146	0.0011	CcSEcCtD
Neostigmine—Asthenia—Gemcitabine—lung cancer	0.000146	0.0011	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—lung cancer	0.000144	0.00109	CcSEcCtD
Neostigmine—Anaphylactic shock—Docetaxel—lung cancer	0.000144	0.00109	CcSEcCtD
Neostigmine—Pruritus—Gemcitabine—lung cancer	0.000144	0.00108	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—lung cancer	0.000143	0.00108	CcSEcCtD
Neostigmine—Diarrhoea—Irinotecan—lung cancer	0.000143	0.00108	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—lung cancer	0.000142	0.00107	CcSEcCtD
Neostigmine—Shock—Docetaxel—lung cancer	0.000142	0.00107	CcSEcCtD
Neostigmine—Nervous system disorder—Docetaxel—lung cancer	0.000141	0.00107	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—lung cancer	0.000141	0.00106	CcSEcCtD
Neostigmine—Tachycardia—Docetaxel—lung cancer	0.000141	0.00106	CcSEcCtD
Neostigmine—Skin disorder—Docetaxel—lung cancer	0.00014	0.00106	CcSEcCtD
Neostigmine—Hypersensitivity—Cisplatin—lung cancer	0.000139	0.00105	CcSEcCtD
Neostigmine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000139	0.00105	CcSEcCtD
Neostigmine—Diarrhoea—Gemcitabine—lung cancer	0.000139	0.00105	CcSEcCtD
Neostigmine—Dizziness—Irinotecan—lung cancer	0.000138	0.00104	CcSEcCtD
Neostigmine—Urticaria—Etoposide—lung cancer	0.000138	0.00104	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—lung cancer	0.000137	0.00103	CcSEcCtD
Neostigmine—Asthenia—Cisplatin—lung cancer	0.000136	0.00102	CcSEcCtD
Neostigmine—Urticaria—Paclitaxel—lung cancer	0.000135	0.00102	CcSEcCtD
Neostigmine—Hypotension—Docetaxel—lung cancer	0.000135	0.00102	CcSEcCtD
Neostigmine—Abdominal pain—Paclitaxel—lung cancer	0.000134	0.00101	CcSEcCtD
Neostigmine—Vomiting—Irinotecan—lung cancer	0.000132	0.001	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—lung cancer	0.000132	0.000994	CcSEcCtD
Neostigmine—Rash—Irinotecan—lung cancer	0.000131	0.000991	CcSEcCtD
Neostigmine—Dermatitis—Irinotecan—lung cancer	0.000131	0.000991	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000131	0.00099	CcSEcCtD
Neostigmine—Headache—Irinotecan—lung cancer	0.000131	0.000985	CcSEcCtD
Neostigmine—Insomnia—Docetaxel—lung cancer	0.00013	0.000983	CcSEcCtD
Neostigmine—Diarrhoea—Cisplatin—lung cancer	0.000129	0.000977	CcSEcCtD
Neostigmine—Vomiting—Gemcitabine—lung cancer	0.000129	0.000974	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—lung cancer	0.000129	0.000972	CcSEcCtD
Neostigmine—Dyspnoea—Docetaxel—lung cancer	0.000128	0.000969	CcSEcCtD
Neostigmine—Somnolence—Docetaxel—lung cancer	0.000128	0.000966	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—lung cancer	0.000128	0.000966	CcSEcCtD
Neostigmine—Rash—Gemcitabine—lung cancer	0.000128	0.000966	CcSEcCtD
Neostigmine—Dermatitis—Gemcitabine—lung cancer	0.000128	0.000965	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—lung cancer	0.000128	0.000964	CcSEcCtD
Neostigmine—Headache—Gemcitabine—lung cancer	0.000127	0.00096	CcSEcCtD
Neostigmine—Hypersensitivity—Paclitaxel—lung cancer	0.000125	0.000945	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—lung cancer	0.000125	0.000943	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000124	0.000938	CcSEcCtD
Neostigmine—Asthenia—Etoposide—lung cancer	0.000124	0.000938	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—lung cancer	0.000124	0.000938	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—lung cancer	0.000124	0.000936	CcSEcCtD
Neostigmine—Nausea—Irinotecan—lung cancer	0.000124	0.000934	CcSEcCtD
Neostigmine—Pruritus—Etoposide—lung cancer	0.000123	0.000925	CcSEcCtD
Neostigmine—Asthenia—Paclitaxel—lung cancer	0.000122	0.00092	CcSEcCtD
Neostigmine—Nausea—Gemcitabine—lung cancer	0.000121	0.00091	CcSEcCtD
Neostigmine—Vomiting—Cisplatin—lung cancer	0.00012	0.000908	CcSEcCtD
Neostigmine—Pruritus—Paclitaxel—lung cancer	0.00012	0.000907	CcSEcCtD
Neostigmine—Rash—Cisplatin—lung cancer	0.000119	0.0009	CcSEcCtD
Neostigmine—Dermatitis—Cisplatin—lung cancer	0.000119	0.000899	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—lung cancer	0.000119	0.000895	CcSEcCtD
Neostigmine—Gastrointestinal pain—Docetaxel—lung cancer	0.000118	0.000889	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—lung cancer	0.000117	0.000886	CcSEcCtD
Neostigmine—Diarrhoea—Paclitaxel—lung cancer	0.000116	0.000877	CcSEcCtD
Neostigmine—Dizziness—Etoposide—lung cancer	0.000115	0.000865	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—lung cancer	0.000114	0.000861	CcSEcCtD
Neostigmine—Abdominal pain—Docetaxel—lung cancer	0.000114	0.000859	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—lung cancer	0.000113	0.000853	CcSEcCtD
Neostigmine—Dizziness—Paclitaxel—lung cancer	0.000112	0.000848	CcSEcCtD
Neostigmine—Nausea—Cisplatin—lung cancer	0.000112	0.000848	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—lung cancer	0.000111	0.000837	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—lung cancer	0.00011	0.000832	CcSEcCtD
Neostigmine—Vomiting—Etoposide—lung cancer	0.00011	0.000832	CcSEcCtD
Neostigmine—Rash—Etoposide—lung cancer	0.000109	0.000825	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—lung cancer	0.000109	0.000824	CcSEcCtD
Neostigmine—Headache—Etoposide—lung cancer	0.000109	0.000819	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—lung cancer	0.000109	0.000819	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—lung cancer	0.000108	0.000817	CcSEcCtD
Neostigmine—Vomiting—Paclitaxel—lung cancer	0.000108	0.000815	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000108	0.000812	CcSEcCtD
Neostigmine—Rash—Paclitaxel—lung cancer	0.000107	0.000809	CcSEcCtD
Neostigmine—Dermatitis—Paclitaxel—lung cancer	0.000107	0.000808	CcSEcCtD
Neostigmine—Headache—Paclitaxel—lung cancer	0.000106	0.000803	CcSEcCtD
Neostigmine—Hypersensitivity—Docetaxel—lung cancer	0.000106	0.000801	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—lung cancer	0.000106	0.000799	CcSEcCtD
Neostigmine—ABCB1—lymph node—lung cancer	0.000106	0.0107	CbGeAlD
Neostigmine—Anaphylactic shock—Methotrexate—lung cancer	0.000104	0.000783	CcSEcCtD
Neostigmine—Asthenia—Docetaxel—lung cancer	0.000103	0.00078	CcSEcCtD
Neostigmine—Nausea—Etoposide—lung cancer	0.000103	0.000777	CcSEcCtD
Neostigmine—Pruritus—Docetaxel—lung cancer	0.000102	0.000769	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—lung cancer	0.000102	0.000768	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—lung cancer	0.000101	0.000764	CcSEcCtD
Neostigmine—Nausea—Paclitaxel—lung cancer	0.000101	0.000762	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—lung cancer	0.000101	0.000761	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—lung cancer	0.0001	0.000757	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—lung cancer	9.88e-05	0.000745	CcSEcCtD
Neostigmine—Diarrhoea—Docetaxel—lung cancer	9.85e-05	0.000744	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—lung cancer	9.7e-05	0.000732	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—lung cancer	9.68e-05	0.000731	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—lung cancer	9.54e-05	0.00072	CcSEcCtD
Neostigmine—Dizziness—Docetaxel—lung cancer	9.52e-05	0.000719	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—lung cancer	9.46e-05	0.000714	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—lung cancer	9.39e-05	0.000709	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—lung cancer	9.38e-05	0.000708	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.31e-05	0.000703	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—lung cancer	9.25e-05	0.000698	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—lung cancer	9.23e-05	0.000697	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—lung cancer	9.17e-05	0.000692	CcSEcCtD
Neostigmine—Vomiting—Docetaxel—lung cancer	9.16e-05	0.000691	CcSEcCtD
Neostigmine—Rash—Docetaxel—lung cancer	9.08e-05	0.000685	CcSEcCtD
Neostigmine—Dermatitis—Docetaxel—lung cancer	9.07e-05	0.000685	CcSEcCtD
Neostigmine—Headache—Docetaxel—lung cancer	9.02e-05	0.000681	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—lung cancer	8.99e-05	0.000678	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—lung cancer	8.96e-05	0.000676	CcSEcCtD
Neostigmine—Shock—Doxorubicin—lung cancer	8.84e-05	0.000667	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—lung cancer	8.82e-05	0.000665	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—lung cancer	8.77e-05	0.000662	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—lung cancer	8.73e-05	0.000659	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—lung cancer	8.69e-05	0.000656	CcSEcCtD
Neostigmine—Nausea—Docetaxel—lung cancer	8.56e-05	0.000646	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—lung cancer	8.49e-05	0.000641	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—lung cancer	8.4e-05	0.000634	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—lung cancer	8.25e-05	0.000622	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—lung cancer	8.21e-05	0.000619	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.19e-05	0.000618	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—lung cancer	8.13e-05	0.000614	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—lung cancer	8.01e-05	0.000605	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—lung cancer	7.99e-05	0.000603	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—lung cancer	7.76e-05	0.000586	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—lung cancer	7.65e-05	0.000577	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—lung cancer	7.45e-05	0.000562	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—lung cancer	7.35e-05	0.000555	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—lung cancer	7.34e-05	0.000554	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—lung cancer	7.14e-05	0.000539	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—lung cancer	7.11e-05	0.000536	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—lung cancer	7.1e-05	0.000536	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—lung cancer	6.86e-05	0.000518	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—lung cancer	6.62e-05	0.0005	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—lung cancer	6.6e-05	0.000498	CcSEcCtD
Neostigmine—Rash—Methotrexate—lung cancer	6.55e-05	0.000494	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—lung cancer	6.54e-05	0.000494	CcSEcCtD
Neostigmine—Headache—Methotrexate—lung cancer	6.5e-05	0.000491	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—lung cancer	6.45e-05	0.000487	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—lung cancer	6.36e-05	0.00048	CcSEcCtD
Neostigmine—Nausea—Methotrexate—lung cancer	6.17e-05	0.000465	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—lung cancer	6.15e-05	0.000464	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—lung cancer	5.94e-05	0.000449	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—lung cancer	5.72e-05	0.000431	CcSEcCtD
Neostigmine—Rash—Doxorubicin—lung cancer	5.67e-05	0.000428	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—lung cancer	5.66e-05	0.000427	CcSEcCtD
Neostigmine—Headache—Doxorubicin—lung cancer	5.63e-05	0.000425	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—lung cancer	5.34e-05	0.000403	CcSEcCtD
Neostigmine—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	4.99e-05	0.00123	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	4.98e-05	0.00123	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2A7—lung cancer	4.93e-05	0.00122	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—LMNA—lung cancer	4.91e-05	0.00121	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.89e-05	0.00121	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.88e-05	0.0012	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM2—lung cancer	4.87e-05	0.0012	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CNDP2—lung cancer	4.87e-05	0.0012	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SDC4—lung cancer	4.83e-05	0.00119	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CXCL8—lung cancer	4.79e-05	0.00118	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	4.74e-05	0.00117	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTMR3—lung cancer	4.74e-05	0.00117	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.66e-05	0.00115	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PGAM1—lung cancer	4.61e-05	0.00114	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP3—lung cancer	4.58e-05	0.00113	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL2—lung cancer	4.58e-05	0.00113	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—BRAF—lung cancer	4.57e-05	0.00112	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.53e-05	0.00112	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	4.49e-05	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—lung cancer	4.47e-05	0.0011	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.41e-05	0.00109	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2A7—lung cancer	4.4e-05	0.00108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—RRM1—lung cancer	4.4e-05	0.00108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA3—lung cancer	4.4e-05	0.00108	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.37e-05	0.00108	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SDC4—lung cancer	4.31e-05	0.00106	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MDM2—lung cancer	4.29e-05	0.00106	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—RAF1—lung cancer	4.27e-05	0.00105	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	4.17e-05	0.00103	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—B4GALT5—lung cancer	4.14e-05	0.00102	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	4.06e-05	0.000999	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA4—lung cancer	4.02e-05	0.000991	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.02e-05	0.00099	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	3.99e-05	0.000982	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.97e-05	0.000977	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.93e-05	0.000968	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—RRM1—lung cancer	3.92e-05	0.000966	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA3—lung cancer	3.92e-05	0.000966	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA2—lung cancer	3.92e-05	0.000965	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AZIN2—lung cancer	3.92e-05	0.000965	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COL4A3BP—lung cancer	3.92e-05	0.000965	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.89e-05	0.000958	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MDM2—lung cancer	3.83e-05	0.000942	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—RAF1—lung cancer	3.81e-05	0.000939	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTA1—lung cancer	3.78e-05	0.000931	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.75e-05	0.000923	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCC3—lung cancer	3.74e-05	0.000921	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.7e-05	0.000911	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—B4GALT5—lung cancer	3.69e-05	0.000909	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKR1C1—lung cancer	3.62e-05	0.000892	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA4—lung cancer	3.59e-05	0.000884	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—UGT1A1—lung cancer	3.52e-05	0.000866	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.51e-05	0.000864	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA2—lung cancer	3.5e-05	0.000861	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.48e-05	0.000856	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.44e-05	0.000848	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNG11—lung cancer	3.39e-05	0.000835	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTA1—lung cancer	3.37e-05	0.000831	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.37e-05	0.000831	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCC3—lung cancer	3.34e-05	0.000822	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ATP5H—lung cancer	3.33e-05	0.000821	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.33e-05	0.000821	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKR1C1—lung cancer	3.23e-05	0.000796	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDOA—lung cancer	3.23e-05	0.000795	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.21e-05	0.000791	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.17e-05	0.000781	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.15e-05	0.000776	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—UGT1A1—lung cancer	3.14e-05	0.000772	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA3—lung cancer	3.13e-05	0.000772	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.08e-05	0.000758	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—lung cancer	3.07e-05	0.000757	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCG2—lung cancer	3.05e-05	0.000751	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADCY1—lung cancer	3.05e-05	0.000751	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP1—lung cancer	3.05e-05	0.00075	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNG11—lung cancer	3.02e-05	0.000745	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.01e-05	0.000741	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.99e-05	0.000736	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HPGDS—lung cancer	2.99e-05	0.000736	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO2—lung cancer	2.99e-05	0.000736	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.98e-05	0.000733	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPP2R1B—lung cancer	2.97e-05	0.000732	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLBD1—lung cancer	2.97e-05	0.000732	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.93e-05	0.000722	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—lung cancer	2.9e-05	0.000714	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOA—lung cancer	2.88e-05	0.000709	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2A6—lung cancer	2.87e-05	0.000706	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GCLC—lung cancer	2.87e-05	0.000706	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.87e-05	0.000706	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.86e-05	0.000703	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.84e-05	0.0007	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.83e-05	0.000698	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.83e-05	0.000698	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.81e-05	0.000693	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA3—lung cancer	2.8e-05	0.000689	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.75e-05	0.000677	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	2.74e-05	0.000675	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCG2—lung cancer	2.72e-05	0.00067	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADCY1—lung cancer	2.72e-05	0.00067	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP1—lung cancer	2.72e-05	0.000669	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO1—lung cancer	2.72e-05	0.000669	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD17B10—lung cancer	2.72e-05	0.000669	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.71e-05	0.000667	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.67e-05	0.000658	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HPGDS—lung cancer	2.67e-05	0.000657	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO2—lung cancer	2.67e-05	0.000657	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPP2R1B—lung cancer	2.65e-05	0.000653	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.63e-05	0.000649	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.62e-05	0.000644	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—lung cancer	2.59e-05	0.000637	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCLC—lung cancer	2.56e-05	0.00063	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2A6—lung cancer	2.56e-05	0.00063	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.55e-05	0.000627	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—POMC—lung cancer	2.53e-05	0.000624	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.53e-05	0.000623	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CKB—lung cancer	2.53e-05	0.000622	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.52e-05	0.00062	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.49e-05	0.000614	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.44e-05	0.0006	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2E1—lung cancer	2.44e-05	0.0006	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO1—lung cancer	2.42e-05	0.000597	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.42e-05	0.000595	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NQO1—lung cancer	2.41e-05	0.000593	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.38e-05	0.000587	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CNDP2—lung cancer	2.38e-05	0.000585	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM2—lung cancer	2.38e-05	0.000585	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.36e-05	0.000581	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—lung cancer	2.36e-05	0.000581	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—lung cancer	2.35e-05	0.00058	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.34e-05	0.000576	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTMR3—lung cancer	2.31e-05	0.000569	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.26e-05	0.000557	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—POMC—lung cancer	2.26e-05	0.000556	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PGAM1—lung cancer	2.25e-05	0.000554	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.2e-05	0.000542	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.2e-05	0.000541	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2E1—lung cancer	2.17e-05	0.000535	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—STK11—lung cancer	2.17e-05	0.000535	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NQO1—lung cancer	2.15e-05	0.000529	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2A7—lung cancer	2.15e-05	0.000529	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.13e-05	0.000525	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.13e-05	0.000523	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.11e-05	0.000518	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—lung cancer	2.1e-05	0.000518	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SDC4—lung cancer	2.1e-05	0.000518	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—lung cancer	2.1e-05	0.000517	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.09e-05	0.000514	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.04e-05	0.000502	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.03e-05	0.000499	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—lung cancer	2.01e-05	0.000495	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.97e-05	0.000485	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—lung cancer	1.96e-05	0.000483	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAT—lung cancer	1.96e-05	0.000482	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.94e-05	0.000479	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—STK11—lung cancer	1.94e-05	0.000477	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.92e-05	0.000473	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA3—lung cancer	1.91e-05	0.000471	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—RRM1—lung cancer	1.91e-05	0.000471	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—lung cancer	1.9e-05	0.000469	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMS—lung cancer	1.87e-05	0.00046	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—lung cancer	1.85e-05	0.000455	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.83e-05	0.00045	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.82e-05	0.000448	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.82e-05	0.000447	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—B4GALT5—lung cancer	1.8e-05	0.000443	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—lung cancer	1.79e-05	0.000442	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.77e-05	0.000435	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA4—lung cancer	1.75e-05	0.000431	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A1—lung cancer	1.75e-05	0.000431	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—lung cancer	1.75e-05	0.00043	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAT—lung cancer	1.74e-05	0.00043	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ERCC2—lung cancer	1.74e-05	0.000428	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.73e-05	0.000427	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.73e-05	0.000425	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA2—lung cancer	1.71e-05	0.00042	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—lung cancer	1.7e-05	0.000418	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMS—lung cancer	1.67e-05	0.000411	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—lung cancer	1.65e-05	0.000406	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA1—lung cancer	1.65e-05	0.000405	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.63e-05	0.000402	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCC3—lung cancer	1.63e-05	0.000401	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKR1C1—lung cancer	1.58e-05	0.000388	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A1—lung cancer	1.56e-05	0.000385	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ERCC2—lung cancer	1.55e-05	0.000382	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UGT1A1—lung cancer	1.53e-05	0.000377	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOA1—lung cancer	1.5e-05	0.00037	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.5e-05	0.000369	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNG11—lung cancer	1.48e-05	0.000363	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.45e-05	0.000357	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.44e-05	0.000354	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOA—lung cancer	1.41e-05	0.000346	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.4e-05	0.000344	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—lung cancer	1.37e-05	0.000338	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA3—lung cancer	1.36e-05	0.000336	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOA1—lung cancer	1.34e-05	0.00033	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCG2—lung cancer	1.33e-05	0.000327	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADCY1—lung cancer	1.33e-05	0.000327	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—POMC—lung cancer	1.31e-05	0.000322	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPGDS—lung cancer	1.3e-05	0.00032	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO2—lung cancer	1.3e-05	0.00032	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.29e-05	0.000318	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.28e-05	0.000316	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CREBBP—lung cancer	1.27e-05	0.000313	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—lung cancer	1.26e-05	0.000311	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCLC—lung cancer	1.25e-05	0.000307	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2A6—lung cancer	1.25e-05	0.000307	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.22e-05	0.000302	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—lung cancer	1.22e-05	0.000301	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—lung cancer	1.21e-05	0.000297	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—lung cancer	1.19e-05	0.000293	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO1—lung cancer	1.18e-05	0.000291	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.18e-05	0.000291	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—POMC—lung cancer	1.16e-05	0.000287	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CREBBP—lung cancer	1.13e-05	0.000279	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.11e-05	0.000272	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—lung cancer	1.08e-05	0.000265	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—lung cancer	1.06e-05	0.000261	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2E1—lung cancer	1.06e-05	0.000261	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—lung cancer	1.05e-05	0.000259	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NQO1—lung cancer	1.05e-05	0.000258	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—lung cancer	1.04e-05	0.000256	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—STK11—lung cancer	9.46e-06	0.000233	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—lung cancer	9.38e-06	0.000231	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—lung cancer	9.29e-06	0.000229	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—lung cancer	9.08e-06	0.000224	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—lung cancer	8.75e-06	0.000215	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EP300—lung cancer	8.66e-06	0.000213	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAT—lung cancer	8.51e-06	0.00021	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMS—lung cancer	8.13e-06	0.0002	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—lung cancer	8.1e-06	0.0002	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—lung cancer	8.04e-06	0.000198	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EP300—lung cancer	7.73e-06	0.00019	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A1—lung cancer	7.62e-06	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ERCC2—lung cancer	7.56e-06	0.000186	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOA1—lung cancer	6.54e-06	0.000161	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—lung cancer	6.41e-06	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—lung cancer	5.97e-06	0.000147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—lung cancer	5.72e-06	0.000141	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—POMC—lung cancer	5.68e-06	0.00014	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CREBBP—lung cancer	5.53e-06	0.000136	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—lung cancer	5.25e-06	0.000129	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—lung cancer	5.23e-06	0.000129	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—lung cancer	5.18e-06	0.000128	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—lung cancer	4.67e-06	0.000115	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—lung cancer	4.57e-06	0.000113	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—lung cancer	4.53e-06	0.000112	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—lung cancer	3.95e-06	9.73e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EP300—lung cancer	3.77e-06	9.28e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—lung cancer	2.79e-06	6.87e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—lung cancer	2.28e-06	5.61e-05	CbGpPWpGaD
